Latest market price
24.67
-0.13-0.52%
OverviewShort InterestFilings
VRDNQT62Viridian Therapeutics, Inc.·NASDAQ
24.67-0.52%

Latest SEC Filings

Form category
DescriptionFilingDocument
Aug 20, 20264Statement of changes in beneficial ownership
Aug 20, 2026SC 13GBeneficial ownership statement (passive)
Aug 18, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 26, 2026SC 13GBeneficial ownership statement (passive)
Jun 03, 20268-KCurrent report
May 28, 20268-KCurrent report
May 26, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 13, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 13, 20264Statement of changes in beneficial ownership
May 11, 20268-KCurrent report
#1 / 25 of 327
Page
▼
/ 14